Skin Cancer
Melanoma of the Trunk
Female, 56 years
Patient Internal ID: 801207744
ICD-10 code
C43.5 Malignant Melanoma of Trunk
Diagnosis (Incl. Metastases/Stage) and Year
April 2021
In 2015 the patient was diagnosed with Stage 2 Melanoma. After resection, no further treatment was required.
In 2021 diagnosis – Cutaneous Melanoma Anterior Chest Wall) pTxN1M1 BRAF V600(+) Stage IV, Multiple Metastases to Lungs, Subcutaneous Tissue, Neck, and Mediastinal Lymph Nodes.
Previous Treatment
Surgery, Target Therapy (Dabrafenib + Trametinib).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of ~1-2 years from diagnosis.
Treatment Provided
Autologous DCV (7 doses) over a period of 8 months.
Patient Survival/Condition and Year
Date of Review: 15/11/2023
The patient has survived for 31 months. She continues active treatment with Target Therapy. It can be concluded that that the addition of Immunotherapy, alongside Surgery and Target Therapy, has extended patient survival for at least 7 months so far.
